PMA device
Organ Care System (OCS) Heart System
TransMedics, Inc. · Organ Care System (Ocs) Heart System (QIK, Class III) · First FDA decision Sep 3, 2021, newest Sep 3, 2021Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
534
Naming "Organ"
MAUDE reports
10
Brand "Organ", since 2015
PubMed studies
430,440
Mentioning "Organ"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Organ Care System (OCS) Heart System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P180051 · Decided Sep 3, 2021 · 982 days after receipt
Device type: Organ care system (OCS) heart system (QIK) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Genomic Sequence Analysis Panels in the Treatment of Solid Organ NeoplasmsLocal determinationIn effectL37810Wellpoint FederalUpdated Jul 16, 2026
- MolDX: Molecular Testing for Solid Organ Allograft RejectionLocal determinationIn effectL40140CGS Administrators, LLCUpdated Jul 10, 2026
- MolDX: Molecular Testing for Solid Organ Allograft RejectionLocal determinationIn effectL40249WPS Insurance CorporationUpdated Jul 10, 2026
- MolDX: Molecular Testing for Solid Organ Allograft RejectionLocal determinationIn effectL40062Noridian Healthcare Solutions, LLCUpdated Jul 9, 2026
- MolDX: Molecular Testing for Solid Organ Allograft RejectionLocal determinationIn effectL40058Palmetto GBAUpdated Jul 8, 2026
- MolDX: Molecular Testing for Solid Organ Allograft RejectionProposed local determinationProposedDL40249WPS Insurance CorporationUpdated Jul 11, 2025
- MolDX: Molecular Testing for Solid Organ Allograft RejectionProposed local determinationProposedDL40062Noridian Healthcare Solutions, LLCUpdated Jul 11, 2025
- MolDX: Molecular Testing for Solid Organ Allograft RejectionProposed local determinationProposedDL40140CGS Administrators, LLCUpdated Jul 10, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Organ", any status and sponsor, newest update first.
- Miniature In-line RespiratorNot yet recruiting
National Institutes of Health Clinical Center (CC)NIH
NCT07768215 · 5 participants (planned) · Start Nov 25, 2026 · Primary completion Dec 1, 2028
Device: Hope inVent · For: Brain Death; Respiration, Artificial
Sites: Philadelphia, Pennsylvania
533 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Organ", and for the whole product code for context.
This brand
10 reports: 6 malfunction, 1 injury, 0 death
Whole product code QIK
27 reports: 17 malfunction, 7 injury, 1 death
Newest reports for this brand
MW6003839 · Received Oct 13, 2026 · Event dated Sep 17, 2026
Device type: Organ Care System (Ocs) Heart System (QIK)
Device problem as coded: Obstruction of Flow; Pumping Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Organ"[tiab]. The summary above synthesizes these.
- Understanding Organ Stewardship.
Shupe E · Hastings Cent Rep · 2024
- Plasma protein-based organ-specific aging and mortality models unveil diseases as accelerated aging of organismal systems.
Goeminne LJE, Vladimirova A, Eames A, et al. · Cell Metab · 2025
- Organ donation in the US and Europe: The supply vs demand imbalance.
Lewis A, Koukoura A, Tsianos GI, et al. · Transplant Rev (Orlando) · 2021Review
- [Pediatric Organ Donation].
Atsumi T · Brain Nerve · 2025Review, English Abstract
- Organ donation protocols.
Maciel CB, Hwang DY, Greer DM · Handb Clin Neurol · 2017Review
- Grand Challenges in Organ Transplantation.
Kupiec-Weglinski JW · Front Transplant · 2022Editorial
- Rare organ manifestations of sarcoidosis.
Albaba I, Feustel PJ, Kenneth MF, et al. · Respir Med · 2022
- Organ-on-a-chip for perinatal biology experiments.
Menon R, Richardson L · Placenta Reprod Med · 2022
- Deceased Organ Donation.
Israni AK, Zaun D, Bolch C, et al. · Am J Transplant · 2016
- Organ procurement in a deceased donor.
Hwang HP, Kim JM, Shin S, et al. · Korean J Transplant · 2020Review
- Organ transplantation in persons with HIV.
Kumar RN, Stosor V · AIDS · 2020Review
- Organ motion and its management.
Langen KM, Jones DT · Int J Radiat Oncol Biol Phys · 2001Review
Other devices of this type
Also filed under product code QIK.
- OCS Heart SystemTransMedics, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.